The effect of gadolinium-based MRI contrast agents on the biodistribution of Ga

Nuclear Medicine Communications

Volumn 23, Issue 2, 2002, Pages 139-145

  Baker, R J ^a  

^a PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Gadolinium DTPA; Gadopentate; Gallium 67 biodistribution

Indexed keywords

CONTRAST MEDIUM; GADODIAMIDE; GADOLINIUM PENTETATE; GALLIUM 67; PENTETIC ACID; PENTETIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; FEMALE; LIGAND BINDING; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; TISSUE DISTRIBUTION;

ANIMALS; CITRATES; FEMALE; GADOLINIUM DTPA; GALLIUM; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; RABBITS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 0036114005     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200202000-00005     Document Type: Article

References (25)

1. Lentle BC, Penney H, Ensslen R. A generalised increase of gallium-67 in bone. Semin Nucl Med 1984; 14: 143-145.
2. Hayes RL. The medical use of gallium radionuclides: a brief history with some comments. Semin Nucl Med 1978; 9: 183-191.
3. Hayes RL, Edwards CL. The effect of stable scandium on red blood cells and on the retention and excretion of Ga-67 in humans. South Med J 1973; 66: 1339-1340.
4. Sephton R, Martin JJ. Modification of distribution of Ga-67 in man by the administration of iron. Br J Radiol 1980; 53: 572-575.
5. Moult RG, Bekerman C. Altered biodistribution of Ga-67 by intramuscular gold salts. Clin Nucl Med 1989; 14: 831-833.
6. Edwards CL, Hayes RL. Tumour scanning with 67 Ga citrate. J Nucl Med 1969; 10: 103-105.
7. 67/stable gadolinium antagonism: MRI contrast agent markedly alters the normal biodistribution of gallium-67. J Nucl Med 1990; 31: 1844-1846.
8. Wiggins JR, Goldstein HA, Weinmann HJ. Gallium-67/stable gadolinium antagonism. J Nucl Med 1991; 32: 1830-1831.
9. Weinmann H-J, Brasch RC, Press WR, Wesbey GE. Characteristics of gadolinium-DTPA: a potential NMR contrast agent. Am J Roent 1984; 142: 619-624.
10. Brasch RC, Weinmann H-J, Wesbey GE. Contrast-enhanced NMR imaging: animal studies using gadolinium-DTPA complex. Am J Roent 1984; 142: 625-630.
11. Pinsky SM, Henkin RE. Gallium-67 tumour scanning. Semin Nucl Med 1976; 6: 397-409.
12. Sephton RG, Hodgson GS, De Abrew S, Harris AW. Ga-67 and Fe-59 distributions in mice. J Nucl Med 1978; 19: 930-935.
13. Maddalena DJ. TISCON: a basic computer program for the calculation of the biodistribution of radiolabelled drugs in rats and mice. Australian Atomic Energy Research Establishment AAEC/E572, 1983.
14. 51Cr. Nucl Med (Stuttgart) 1968; 7: 286-292.
15. Martell AE, Smith RM. Critical stability constants . Volume 1: amino acids. New York: Plenum Press, 1974: 284.
16. Radpharm Scientific, Canberra, Australia. DTPA product information, 1998.
17. Amersham International plc. Pentetate II product information, 1989.
18. Niendorf NP, Dinger JC Haustein J, et al. Tolerance data of Gd-DTPA: a review. Eur J Radiol 1991; 13: 15-20.
19. Koizumi K, Uchiyama G, Araki T, et al. Visualisation of the bone/bone marrow of lower extremities in Ga-67 whole-body images. Ann Nucl Med 1990; 4: 15.
20. Aisen P, Leibman A, Zweier J. Stoichiometry and site characteristics of the binding of iron to human transferrin. J Biol Chem 1978; 253: 1930-1937.
21. Harris WR, Peccarro VL. Thermodynamic binding constants for gallium transferrin. Biochem 1983; 22: 292-299.
22. Zac O, Aisen P. Spectroscopic and thermodynamic studies on the binding of gadolinium(III) to human transferrin. Biochem 1988; 27: 1075-1080.
23. Sillen LG, Martell AE. Stability constants of metal-ion complexes. Special publication No. 17. London: The Chemical Society, 1964. Also, Supplement, Special Publication No. 25, 1971.
24. Jackson GE, Byrne MJ. Metal ion speciation in blood plasma: Gallium-67-citrate and MRI contrast agents. J Nucl Med 1996; 37: 379-386.
25. Sohn MH, Jones BJ, Whiting Jr JH, Datz FL, Lynch RE, Morton KA. Distribution of gallium-67 in normal and hypotransferrinemic tumour-bearing mice. J Nucl Med 1993; 34: 2135-2143.